| - GRCh37:
- Chr20:3193977
- GRCh38:
- Chr20:3213331
| ITPA | Q29fs, Q46fs | Developmental and epileptic encephalopathy, 35 | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr20:3193982
- GRCh38:
- Chr20:3213336
| ITPA | E31*, E48* | Developmental and epileptic encephalopathy, 35 | Pathogenic (Feb 23, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr20:3204161
- GRCh38:
- Chr20:3223515
| ITPA | Q101* | Developmental and epileptic encephalopathy, 35 | Uncertain significance (Feb 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr20:3195926
- GRCh38:
- Chr20:3215280
| ITPA | | Inosine triphosphatase deficiency, Developmental and epileptic encephalopathy, 35 | Pathogenic/Likely pathogenic (May 2, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:3204084
- GRCh38:
- Chr20:3223438
| ITPA | S75N | not provided, Developmental and epileptic encephalopathy, 35, Inosine triphosphatase deficiency
| Benign (Oct 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:3193978
- GRCh38:
- Chr20:3213332
| ITPA | | Developmental and epileptic encephalopathy, 35, not provided, not specified, Inosine triphosphatase deficiency | Benign (Oct 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:3190266
- GRCh38:
- Chr20:3209620
| ITPA | | Developmental and epileptic encephalopathy, 35 | Uncertain significance (May 20, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr20:3193976-3193978
- GRCh38:
- Chr20:3213330-3213332
| ITPA | Q29*, Q46* | Developmental and epileptic encephalopathy, 35 | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr20:3202491
- GRCh38:
- Chr20:3221845
| ITPA | R98Q, G27R, R139Q, R122Q | Inborn genetic diseases, Inosine triphosphatase deficiency, Developmental and epileptic encephalopathy, 35
| Conflicting interpretations of pathogenicity (Oct 28, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr20:3199169
- GRCh38:
- Chr20:3218523
| ITPA | H101R, H60R, H84R | Inosine triphosphatase deficiency, Developmental and epileptic encephalopathy, 35 | Uncertain significance (Jul 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:3195934
- GRCh38:
- Chr20:3215288
| ITPA | F50L, F74L, F91L | Developmental and epileptic encephalopathy, 35 | Likely pathogenic (Feb 15, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr20:3195287-3197161
- GRCh38:
- Chr20:3214641-3216515
| ITPA | | Developmental and epileptic encephalopathy, 35 | Pathogenic (Aug 5, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr20:3193874
- GRCh38:
- Chr20:3213228
| ITPA | | Developmental and epileptic encephalopathy, 35, Inosine triphosphatase deficiency | Pathogenic/Likely pathogenic (May 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:3199183
- GRCh38:
- Chr20:3218537
| ITPA | G106R, G65R, G89R | Developmental and epileptic encephalopathy, 35, Inosine triphosphatase deficiency | Uncertain significance (Aug 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:3193872
- GRCh38:
- Chr20:3213226
| ITPA | | not provided, Inosine triphosphatase deficiency, Inosine triphosphatase deficiency, Developmental and epileptic encephalopathy, 35 | Likely benign (Oct 28, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:3195941
- GRCh38:
- Chr20:3215295
| ITPA | E93G, E52G, E76G | Developmental and epileptic encephalopathy, 35, Inosine triphosphatase deficiency, not specified, Inosine triphosphatase deficiency, not provided | Benign/Likely benign (Nov 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:3202563
- GRCh38:
- Chr20:3221917
| ITPA | T163M, T122M, T146M, R51C | Developmental and epileptic encephalopathy, 35, Inosine triphosphatase deficiency | Uncertain significance (Nov 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:3199224-3199225
- GRCh38:
- Chr20:3218578-3218579
| ITPA | G106fs, G82fs, G11fs, G123fs | Partial congenital absence of teeth, not provided, Developmental and epileptic encephalopathy, 35, Inosine triphosphatase deficiency | Pathogenic/Likely pathogenic (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:3204055
- GRCh38:
- Chr20:3223409
| ITPA | R178C, R161C, R137C | ITPA-related condition, not provided, Inosine triphosphatase deficiency
| Conflicting interpretations of pathogenicity (Jul 20, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr20:3202527
- GRCh38:
- Chr20:3221881
| ITPA | W151*, G39R, W110*, W134* | not provided, Inosine triphosphatase deficiency | Pathogenic (Aug 31, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:3195320-3197225
- GRCh38:
- Chr20:3214674-3216579
| ITPA | | Developmental and epileptic encephalopathy, 35 | Pathogenic (Oct 1, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr20:3193893
- GRCh38:
- Chr20:3213247
| ITPA | | peginterferon alfa-2b and ribavirin response - Toxicity | drug response (Mar 24, 2021) | reviewed by expert panel |